Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 87 entries
View as:

Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT05888636 Org: User:
Start: 06/18/19 End: 12/31/24 Due: 12/31/25

Analysis and Evaluation of Smoking Treatment With Cytisine

Phase: N/A Priority: Normal
NCT ID: NCT06439303 Org: User:
Start: 03/20/24 End: 06/20/24 Due: 06/20/25

External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT06224244 Org: User:
Start: 02/01/22 End: 01/01/25 Due: 01/01/26

The Effects of TAP Block on Postsurgical Pain After Minimally Invasive Partial Nephrectomy:

Phase: N/A Priority: Normal
NCT ID: NCT02460640 Org: User:
Start: 05/31/15 End: 08/31/17 Due: 08/31/18

Radiological Evaluation of 3D Printed Porous Collars in Hip and Knee Resection Prostheses: Pilot Study.

Phase: N/A Priority: Normal
NCT ID: NCT06180525 Org: User:
Start: 12/01/22 End: 06/01/24 Due: 06/01/25

Biobanking and New Biomolecular Metrics

Phase: N/A Priority: Normal
NCT ID: NCT05906277 Org: User:
Start: 01/29/19 End: 12/31/25 Due: 12/31/26

Approaches and Metrics in Fraily Patients During COVID-19 Era

Phase: N/A Priority: Normal
NCT ID: NCT05792891 Org: User:
Start: 12/22/20 End: 11/23/22 Due: 11/23/23

Application of Patient Blood Management in the Oncology Patient Affected by Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06883201 Org: User:
Start: 01/31/23 End: 06/30/25 Due: 06/30/26

Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary Cancers

Phase: N/A Priority: Normal
NCT ID: NCT06717711 Org: User:
Start: 08/31/24 End: 08/31/26 Due: 08/31/27

Tolerability and Efficacy of Adjuvant T-DM1 in Patients with HER2 Positive Breast Cancer After Incomplete Pathological Response to Neoadjuvant Chemotherapy Including Anti-HER2 Agents.

Phase: N/A Priority: Normal
NCT ID: NCT06272799 Org: User:
Start: 09/20/22 End: 09/20/24 Due: 09/20/25

Generation of Organotypic Liver Cultures for the Identification of Biomarkers for the Prevention and Treatment of Liver Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT06252272 Org: User:
Start: 01/17/23 End: 01/17/25 Due: 01/17/26

The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients.

Phase: N/A Priority: Normal
NCT ID: NCT04774133 Org: User:
Start: 02/14/19 End: 01/01/22 Due: 01/01/23

Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05789667 Org: User:
Start: 05/27/20 End: 12/31/25 Due: 12/31/26

Clinical Outcomes and Costs Analyses in Use of Goal Directed Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01995786 Org: User:
Start: 01/31/12 End: - Due: -

New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06097936 Org: User:
Start: 03/15/21 End: 04/01/24 Due: 04/01/25

Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus

Phase: N/A Priority: Normal
NCT ID: NCT05918510 Org: User:
Start: 04/04/22 End: 04/04/29 Due: 04/04/30

Quality of Awakening and Impact on Cognitive Function After Administration of Sugammadex in Robotic Radical Cystectomy

Phase: N/A Priority: Normal
NCT ID: NCT02454504 Org: User:
Start: 03/31/15 End: 08/31/16 Due: 08/31/17

The Role of the Free/Pedunculated Flap in Total Laryngectomy After (Chemo-)Radiotherapy Failure for Laryngeal Carcinoma: Impact on the Risk of Pharyngocutaneous Fistula (PCF)

Phase: N/A Priority: Normal
NCT ID: NCT06287034 Org: User:
Start: 03/21/23 End: 09/21/25 Due: 09/21/26

Ten Fraction Adjuvant Hypofractionated Radiotherapy in Node Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04792346 Org: User:
Start: 01/01/15 End: 03/02/21 Due: 03/02/22

From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06273878 Org: User:
Start: 01/15/23 End: 01/15/25 Due: 01/15/26

Randomized Clinical Trial Aimed at Comparing Unclamped Robotic Partial Nephrectomy With or Without Renorrhaphy

Phase: N/A Priority: Normal
NCT ID: NCT06846112 Org: User:
Start: 07/07/23 End: 07/07/28 Due: 07/07/29

Development of Organoids From Primary Colorectal Tumors and Synchronous Liver Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06787625 Org: User:
Start: 05/25/24 End: 05/25/28 Due: 05/25/29

Study of the Contribution of Mutant p53/YAP Proteins to Therapy Resistance in Recurrent Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06791941 Org: User:
Start: 03/07/24 End: 03/07/29 Due: 03/07/30

Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging and Virtual Reality

Phase: N/A Priority: Normal
NCT ID: NCT05918536 Org: User:
Start: 05/17/22 End: 11/17/25 Due: 11/17/26

Biomarkers of Efficacy and Tolerability of Sacituzumab-Govitecan in the Treatment of Patients With Triple-negative Breast Cancer in the Metastatic Phase: Prospective Multicenter Real-world Study

Phase: N/A Priority: Normal
NCT ID: NCT06240195 Org: User:
Start: 01/17/23 End: 06/17/25 Due: 06/17/26